Refine Search

  •  
  •  
Business events scheduled for the coming week

...financial results before the market opens.Merck & Co. reports quarterly financial results before the market opens.Pfizer Inc. reports quarterly financial results before the market opens.Restaurant Brands International Inc. reports quarterly...

http://chronicle.augusta.com/news/business/2015-10-23/business-events-scheduled-
Pfizer doubling patient income limit for program that distributes 40-plus medicines for free

...the entire industry a black eye, the biggest U.S.-based drugmaker is expanding financial assistance to patients.Pfizer Inc. says it's doubling its income limit for people to receive dozens of its medicines without a copayment because more...

http://chronicle.augusta.com/news/business/2015-11-05/pfizer-doubling-patient-in
Science, industry economics, patients are boosting research on rare disease drugs - and hope

...nearly assured.Big drugmakers do not disclose how much they invest in rare diseases. The returns can be huge, though.Pfizer Inc. made $3.53 billion last year selling rare-disease treatments, not counting its 10 cancer drugs for patients with...

http://chronicle.augusta.com/news/business/2015-03-25/science-industry-economics
Drugmaker AstraZeneca rejects $119 billion offer from Pfizer

...with the company's share price slumping 11.1 percent to 42.87 pounds.Johansson said his management team had told Pfizer Inc. over the weekend that it would need to see a 10 percent improvement over the 53.50 pounds-per-share offer that...

http://chronicle.augusta.com/news/business/2014-05-19/board-uk-drugmaker-astraze
Biz Bits

Pfizer makes case for deal in UK filingsLONDON - Pfizer Inc. wants to allay concerns over its proposed $106 billion takeover offer of pharmaceuticals firm AstraZeneca, insisting that its...

http://chronicle.augusta.com/news/business/2014-05-12/biz-bits
AstraZeneca rejects sweetened Pfizer takeover bid

...given up on a deal after British drugmaker AstraZeneca flatly rejected its latest takeover bid, worth $106 billion.Pfizer Inc., the world's second-biggest drugmaker by revenue, made a third unsuccessful attempt for its London-based rival...

http://chronicle.augusta.com/news/business/2014-05-02/astrazeneca-rejects-sweete
Who pays your doc? Coming soon to a site near you

...doctors by name to see what payments they've received. The database covers 15 pharmaceutical companies, including Pfizer Inc. and Johnsons & Johnson, and begins with payments made in 2009.But how is a layperson to make sense of it all? And...

http://chronicle.augusta.com/news/business/2014-07-13/who-pays-your-doc-coming-s
Indian drugmaker recalls generic Lipitor doses

...could compete with brand-name Lipitor. Ranbaxy had that right, although an authorized generic from Lipitor maker Pfizer Inc. and partner Watson Pharmaceuticals Inc. went on sale on Dec. 1. With competition so limited, the generic prices only...

http://chronicle.augusta.com/news/business/2012-11-23/indian-drugmaker-recalls-g
Stock milestones could fuel recovery

...1,300.Investors found plenty of reasons to send stocks sharply higher. Earnings reports from companies including Pfizer Inc., United Parcel Service Inc. and Archer Daniels Midland Co. were better than expected.Manufacturing, which has...

http://chronicle.augusta.com/news/business/2011-02-01/stock-milestones-could-fue
Business
biz bits

...Japan halts use of vaccine after deathsTOKYO --- Japan has temporarily stopped using vaccines from U.S. drugmaker Pfizer Inc. and Sanofi-Aventis SA of France while it investigates the deaths of four children who were inoculated, the health...

http://chronicle.augusta.com/news/business/biz-bits/2011-03-07/biz-bits
Biz Bits | Business